BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17498960)

  • 1. Alkylation potency and protein specificity of aromatic urea derivatives and bioisosteres as potential irreversible antagonists of the colchicine-binding site.
    Fortin JS; Lacroix J; Desjardins M; Patenaude A; Petitclerc E; C-Gaudreault R
    Bioorg Med Chem; 2007 Jul; 15(13):4456-69. PubMed ID: 17498960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Phenyl-N'-(2-chloroethyl)ureas (CEUs) as potential antineoplastic agents. Part 3: role of carbonyl groups in the covalent binding to the colchicine-binding site.
    Moreau E; Fortin S; Lacroix J; Patenaude A; Rousseau JL; C-Gaudreault R
    Bioorg Med Chem; 2008 Feb; 16(3):1206-17. PubMed ID: 17998163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents.
    Legault J; Gaulin JF; Mounetou E; Bolduc S; Lacroix J; Poyet P; Gaudreault RC
    Cancer Res; 2000 Feb; 60(4):985-92. PubMed ID: 10706114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Phenyl-N'-(2-chloroethyl)ureas (CEU) as potential antineoplastic agents. Part 2: role of omega-hydroxyl group in the covalent binding to beta-tubulin.
    Fortin S; Moreau E; Patenaude A; Desjardins M; Lacroix J; Rousseau JL; C-Gaudreault R
    Bioorg Med Chem; 2007 Feb; 15(3):1430-8. PubMed ID: 17118664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of N-phenyl-N'-(2-chloroethyl)ureas in the colchicine-binding site at the interface between alpha- and beta-tubulin.
    Fortin S; Wei L; Moreau E; Labrie P; Petitclerc E; Kotra LP; C-Gaudreault R
    Bioorg Med Chem; 2009 May; 17(10):3690-7. PubMed ID: 19398206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance.
    Petitclerc E; Deschesnes RG; Côté MF; Marquis C; Janvier R; Lacroix J; Miot-Noirault E; Legault J; Mounetou E; Madelmont JC; C -Gaudreault R
    Cancer Res; 2004 Jul; 64(13):4654-63. PubMed ID: 15231678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, antiproliferative activity evaluation and structure-activity relationships of novel aromatic urea and amide analogues of N-phenyl-N'-(2-chloroethyl)ureas.
    Fortin S; Moreau E; Lacroix J; Côté MF; Petitclerc E; C-Gaudreault R
    Eur J Med Chem; 2010 Jul; 45(7):2928-37. PubMed ID: 20400211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective alkylation of beta(II)-tubulin and thioredoxin-1 by structurally related subsets of aryl chloroethylureas leading to either anti-microtubules or redox modulating agents.
    Fortin JS; Côté MF; Lacroix J; Desjardins M; Petitclerc E; C-Gaudreault R
    Bioorg Med Chem; 2008 Aug; 16(15):7277-90. PubMed ID: 18617414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the covalent binding of N-phenyl-N'-(2-chloroethyl)ureas to {beta}-tubulin: importance of Glu198 in microtubule stability.
    Fortin S; Bouchon B; Chambon C; Lacroix J; Moreau E; Chezal JM; Degoul F; C-Gaudreault R
    J Pharmacol Exp Ther; 2011 Feb; 336(2):460-7. PubMed ID: 20978170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatic 2-chloroethyl urea derivatives and bioisosteres. Part 2: Cytocidal activity and effects on the nuclear translocation of thioredoxin-1, and the cell cycle progression.
    Fortin JS; Côté MF; Lacroix J; Petitclerc E; C-Gaudreault R
    Bioorg Med Chem; 2008 Aug; 16(15):7477-88. PubMed ID: 18579387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Phenyl-N'-(2-chloroethyl)urea analogues of combretastatin A-4: Is the N-phenyl-N'-(2-chloroethyl)urea pharmacophore mimicking the trimethoxy phenyl moiety?
    Fortin S; Moreau E; Lacroix J; Teulade JC; Patenaude A; C-Gaudreault R
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2000-4. PubMed ID: 17291753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative molecular field and comparative molecular similarity indices analyses (CoMFA and CoMSIA) of N-phenyl-N'-(2-chloroethyl)ureas targeting the colchicine-binding site as anticancer agents.
    Fortin S; Labrie P; Moreau E; Wei L; Kotra LP; C-Gaudreault R
    Bioorg Med Chem; 2008 Feb; 16(4):1914-26. PubMed ID: 18023585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkylation of beta-tubulin on Glu 198 by a microtubule disrupter.
    Bouchon B; Chambon C; Mounetou E; Papon J; Miot-Noirault E; Gaudreault RC; Madelmont JC; Degoul F
    Mol Pharmacol; 2005 Nov; 68(5):1415-22. PubMed ID: 16099845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkylation of prohibitin by cyclohexylphenyl-chloroethyl urea on an aspartyl residue is associated with cell cycle G(1) arrest in B16 cells.
    Bouchon B; Papon J; Communal Y; Madelmont JC; Degoul F
    Br J Pharmacol; 2007 Oct; 152(4):449-55. PubMed ID: 17704829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroethyl urea derivatives block tumour growth and thioredoxin-1 nuclear translocation.
    Patenaude A; Fortin JS; Deschenes R; Côté MF; Lacroix J; C-Gaudreault R; Petitclerc E
    Can J Physiol Pharmacol; 2010 Nov; 88(11):1102-14. PubMed ID: 21076498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramolecular cyclization of N-phenyl N'(2-chloroethyl)ureas leads to active N-phenyl-4,5-dihydrooxazol-2-amines alkylating β-tubulin Glu198 and prohibitin Asp40.
    Trzeciakiewicz A; Fortin S; Moreau E; C-Gaudreault R; Lacroix J; Chambon C; Communal Y; Chezal JM; Miot-Noirault E; Bouchon B; Degoul F
    Biochem Pharmacol; 2011 May; 81(9):1116-23. PubMed ID: 21371445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Styryl-N-phenyl-N'-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model.
    Gagné-Boulet M; Fortin S; Lacroix J; Lefebvre CA; Côté MF; C-Gaudreault R
    Eur J Med Chem; 2015 Jul; 100():34-43. PubMed ID: 26069928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized N-phenyl-N'-(2-chloroethyl)ureas as potential antineoplastic agents: synthesis and growth inhibition activity.
    Moreau E; Fortin S; Desjardins M; Rousseau JL; Petitclerc E; C-Gaudreault R
    Bioorg Med Chem; 2005 Dec; 13(24):6703-12. PubMed ID: 16165366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization.
    Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Balzarini J; Hadfield JA; Brancale A; Hamel E
    J Med Chem; 2007 May; 50(9):2273-7. PubMed ID: 17419607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimitotic antitumor agents: synthesis, structure-activity relationships, and biological characterization of N-aryl-N'-(2-chloroethyl)ureas as new selective alkylating agents.
    Mounetou E; Legault J; Lacroix J; C-Gaudreault R
    J Med Chem; 2001 Mar; 44(5):694-702. PubMed ID: 11262080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.